Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
BUB
vs
S
S&P/ASX 300
BUB
Over the past 12 months, BUB has underperformed S&P/ASX 300, delivering a return of -32% compared to S&P/ASX 300's 3% drop.
Stocks Performance
BUB vs S&P/ASX 300
Performance Gap
BUB vs S&P/ASX 300
Performance By Year
BUB vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Bubs Australia Ltd
Glance View
Bubs Australia makes infant formula and baby nutrition products, with a strong focus on goat milk formula alongside cow milk-based formula and other early-life nutrition items. It sells these products under its own brands through supermarkets, pharmacies, baby stores, and online channels, and it also supplies products into overseas markets through distributors and trade partners. Its main customers are parents and caregivers looking for formula and toddler nutrition, plus retailers and distributors that stock and resell the products. The company makes money by manufacturing branded consumer products and selling them through retail and export channels, so its business depends on both shelf space at home and demand in key overseas markets. What sets Bubs apart is its role as a specialist in infant formula rather than a broad food company. Goat milk formula is its best-known niche, and that gives it a clear position with families who want an alternative to standard cow milk formula. In practice, Bubs sits in the middle of the baby nutrition supply chain: it develops the products, produces or sources them, and then sells them to shoppers and trade customers through branded channels.